[Stock Request] Biomerica Inc. (BMRA)

"In the announcement, Biomerica said that it has begun shipping its initial samples of a COVID-19 rapid test outside of the United States. The test is a finger prick blood test that provides results within 10 minutes at point of care.

Moreover, the test is highly portable. This means that it can be given at airports, schools, work places, pharmacies, doctors’ offices and more.

Importantly, BMRA said that it is well positioned to begin fulfilling large international orders as long as shipping channels remain active."